The global Molecular Cytogenetics Market size
is expected to reach USD 3. 8 billion
by 2025, according to a new report
by Grand View Research, Inc., exhibiting a 10.4%
CAGR during the forecast period. Mapping of human genome, coupled with
continuous technological advancements in cytogenetic techniques, has enabled
researchers to gain insight into the disease-causing mechanism at a genomic as
well as cellular level. Development in molecular technologies has helped in
bridging the gap between molecular biology and cytogenetics, which was not
possible using conventional cytogenetic techniques.
There is a continuous growth in awareness, and consequent
adoption, of genetic tests for disease prognosis. These tests also help in
designing further treatment regimes for widespread chromosomal abnormalities.
This is sure to boost market growth.
Incorporation of high throughput sequencers in
cytogenetic analysis is expected to significantly enhance market growth in the
coming years. A number of researchers and scientists have begun converging
cytogenetics laboratories with NGS as they complement each other. Hence, with
exponential decline in sequencing price, this market is expected to grow at a
lucrative pace.
However, ambiguous regulatory and reimbursement scenario
in certain regions pertaining to implementation of genetic tests is expected to
hamper the adoption of molecular cytogenetic techniques to a certain extent.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market
https://www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market
Further key findings from the report suggest:
- Oncology held the largest share in the market in 2016 owing to the
ability of CGH technology to facilitate in-depth studies for cancer
etiology
- Use of molecular cytogenetics in personalized medicine development
is expected to grow lucratively during the forecast period. This is
majorly due to a continuous shift toward targeted therapies for effective
disease management
- Requirement of consumables in the entire cytogenetics process is
attributive for the largest share of this product category
- Ongoing research projects for developing treatment regimen of
different genetic conditions have allowed clinical and research
laboratories to gain a significant share in the market
- Pharmaceutical and biotech companies are expected to be a key
source of revenue in the coming years. This is mainly because a number of
pharmaceutical companies have expanded their business in the field of
personalized medicine
- Illumina, Inc.; Agilent Technologies, Inc.; Abbott; Bio-Rad
Laboratories, Inc.; and Oxford Gene Technology are some prominent
companies in the market. They are involved in development and
commercialization of cytogenetics techniques
- Some major service providers are Weill Cornell Medicine; WiCell
Research Institute, Inc.; ARUP Laboratories; and Integrated Systems
Engineering S.r.l.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment